From: ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature
Ā | N | %/range |
---|---|---|
Age, years (n = 47) | 38 | 9 ā 72 |
Sex (n = 50) | Ā | Ā |
āāāMale | 38 | 76 |
āāāFemale | 12 | 24 |
Site of involvement (n = 46) | Ā | Ā |
Exclusively nodal | 24 | 52 |
āāāCervical | 17 | 71 |
āāāOther | 7 | 29 |
Extranodal | 22 | 48 |
āāāBone | 8 | 36 |
āāāLiver and spleen | 4 | 18 |
āāāHead and neck | 3 | 14 |
āāāGastrointestinal tract | 3 | 14 |
āāāOther* | 8 | 36 |
Clinical stage (n = 47) | Ā | Ā |
āāāI ā II | 20 | 43 |
āāāIII ā IV | 27 | 57 |
Therapy (n = 41) | Ā | Ā |
āāāChemotherapy | 34 | 83 |
āāāChemoradiotherapy | 6 | 15 |
āāāRadiotherapy | 1 | 2 |
Relapsed cases | 18 | 44 |
Salvage HSCT | 8 | 20 |
Survival time, months (n = 36) | 24 | 3 ā 156 |